Latest News

November 19, 2013
Janet Napolitano, the University of California’s newly appointed president, visited UCSF this week for the eighth stop of her “listening and learning” tour of all 10 campuses.
November 15, 2013
Precision Medicine Pillar No. 5: Omics Medicine. Molecular biologist Nevan Krogan's work is not only illuminating how genes and proteins function, it's also shedding light on the underlying biology of disease for each person.
November 15, 2013
Precision Medicine Pillar No. 4: Computational Health Sciences. Computationally intensive approaches are used to analyze and cross-analyze large but discrete collections of data, such as patient health histories and genetic makeup.
November 15, 2013
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
November 15, 2013
Precision Medicine Pillar No. 2: Basic Discovery. The long path to developing potent new treatments often starts with an observation in the lab that then leads to a question about a fundamental life process.
November 15, 2013
Precision Medicine Pillar No. 1: Knowledge Network. With an increased ability to harvest information automatically and more powerfully, scientists can find the connections among discoveries that would otherwise go unrecognized.
November 15, 2013
Today, with a host of tools garnered from precision medicine, patients can benefit from precise and effective therapies for some of the world's most daunting illnesses. UCSF Magazine explores the promise of precision medicine.
November 15, 2013
Precision Medicine Pillar No. 6: Digital Health. The Center for Digital Health Innovation shepherds the development of digital health innovations created at UCSF and validates the effectiveness of devices from both inside and outside the institution.
November 14, 2013
For the worst cases of type 1 diabetes, islet transplantation has freed hundreds of people from complete insulin dependence. UCSF is leading a push to bring this experimental procedure into the mainstream.
November 14, 2013
With inexpensive genetics kits flooding the market, both consumers — and their doctors — still lack basic information about what to do, if anything, with what they learn about their own genomes.

Pages